Integrated Diagnostics Holdings plc (LON:IDHC)
London
· Delayed Price · Currency is GBP · Price in USD 0.600
0.00 (0.00%)
Apr 28, 2026, 4:35 PM GMT
LON:IDHC Revenue
In the year 2025, Integrated Diagnostics Holdings had annual revenue of 7.86B EGP with 37.34% growth. Integrated Diagnostics Holdings had revenue of 2.07B in the quarter ending December 31, 2025, with 28.56% growth.
Revenue
7.86B EGP
Revenue Growth
+37.34%
P/S Ratio
2.10
Revenue / Employee
1.25M EGP
Employees
6,309
Market Cap
257.43M GBP
Revenue Chart
* This company reports financials in EGP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.86B | 2.14B | 37.34% |
| Dec 31, 2024 | 5.72B | 1.60B | 38.74% |
| Dec 31, 2023 | 4.12B | 517.46M | 14.35% |
| Dec 31, 2022 | 3.61B | -1.62B | -31.00% |
| Dec 31, 2021 | 5.22B | 2.57B | 96.69% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Avacta Group | 113.00K |
| PureTech Health | 4.66M |
| NIOX Group | 48.70M |
| Optima Health | 113.75M |